Goodwill Protocol Signed at PAU
09.06.2023
Glaxosmithkline Drugs Inc. Co. (GSK) and Pamukkale University Clinical Application and Research Center (PÜKAM) signed a goodwill protocol to increase the potential for collaboration for clinical studies related to existing R&D products.
The PEER (Partnership, Engagement, Excellence in Research) protocol, established by GSK and including PÜKAM, aims to establish bilateral partnership models with selected, high-performing and high-potential institutions with the common goal of improving overall study performance by enhancing study performance and accelerating key study milestones.
